O'Callaghan, M. J., and Ekert, H. (1976) . Archives of Disease in Childhood, 51, 289. Vincristine toxicity unrelated to dose. Four children with vincristine toxicity unrelated to dose are described. Fever, haematological toxicity, and abdominal distension occurred 2-7 days after vincristine was given. Convulsions occurred 6-8 days after vincristine in all 4. Inappropriate secretion of antidiuretic hormone was thought to have occurred in 3 patients. 2 patients died during the acute toxicity phase. Necropsy findings did not show neuronal changes which could be directly ascribed to vincristine.
The vinca alkaloid vincristine is widely used in the treatment of leukaemia and solid tumours in childhood. Neurotoxicity is a common toxic manifestation and often limits the dose of the drug that can be given. This neurotoxicity has been well detailed in recent review articles (Weiss, Walker, and Wiernik, 1974; Rosenthal and Kaufman, 1974) . Severe neurotoxicity can also occur after quite small doses of vincristine, and convulsions and coma have been reported where no other factors (e.g. infection, tumour invasion) seemed to be operating (Johnson et al., 1973; Martin and Mainwaring, 1973; Whittaker et al., 1973) . Hyponatraemia, occasionally associated with convulsions, has also been described and attributed to inappropriate antidiuretic hormone (ADH) secretion (Fine, Clarke, and Shore, 1966; Slater, Wainer, and Serpick, 1969) . Some of these patients had raised ADH levels (Suskind, Brusilow, and Zehr, 1972; Robertson, Bhoopalam, and Zelkowitz, 1973; Stuart et al., 1975) . Recovery from the acute toxic effects of the drug occurred in all the reported cases, except in that of Weiden and Wright (1972) where the patient died of bronchopneumonia after vincristine-induced paraplegia.
We report 4 cases of nondose-related vincristine toxicity. 2 patients died during the phase of vincristine toxicity and necropsy findings are described. The child then improved and irradiation was begun. 3 weeks after completing radiation therapy the first dose of vincristine and actinomycin D of her secondary course was administered. Several hours after administration of these drugs she started vomiting and 48 hours later was admitted to hospital seriously ill. Apart from fever, mouth ulcers, and mild dehydration the clinical examination was normal. The peripheral blood film showed Hb 11g/dl, total white cell count 2100/mm', and platelets 20 000/am'3. Neutropenia and thrombocytopenia became more marked and persisted for the remainder of the illness. Blood cultures were taken and intravenous gentamicin and cephaloridine given. Blood cultures showed no bacterial growth.
The abdomen became markedly distended 3 days after vincristine injection. Electrolytes taken at this time showed a serum sodium 123 mEq/l, potassium 4-3 mEq/l, and urea 24 mg/100ml, while the urine osmolality was 745 mOsm/kg. Unfortunately it was impossible to obtain a blood specimen for estimation of serum osmolality. Over the next 2 days on a regimen of fluid restriction electrolytes returned to normal, abdominal distension diminished, and fever abated. On the evening of day 6 after administration of chemotherapy she was noted to be drowsy. Examination was normal apart from crepitations in both lower lungs.
Over the next few hours she was more alert but later that evening she suddenly convulsed and became comatose. There were no localizing neurological signs. Investigation showed normal electrolytes, blood sugar, and a mild metabolic acidosis with normal Pco3. CSF showed no cells, protein 20 mg/lOOml, sugar 45 mg/ 100ml. Chest x-ray showed patchy consolidation of right lower and middle lobes. Over the next 4 hours, during which time twitching of the right arm was observed, she again improved but later that night a sudden cardiorespiratory arrest occurred and she died.
Necropsy findings, There was evidence of haemorrhagic pneumonia from which Staphylococcus aureus was cultured. The brain was macroscopically normal with no evidence of subarachnoid haemorrhage or infiltration. Light microscope sections of medulla, cerebellum, thalamus, basal ganglia, and frontal cortex showed only moderate vascular congestion. In the pons the periaqueductal grey matter showed mild vacuolation and some neurons showed infolding of the nuclear membrane resulting in a notched appearance. The sections taken for electron microscopy were technically unsatisfactory and could not be interpreted.
Case 2. This child presented at the age of 31 years with acute lymphocytic leukaemia. Apart from prolonged neutropenia the induction with vincristine (2 mg/m2) and prednisolone was uncomplicated. 6 months later she was given craniospinal radiotherapy (3000 rads) because of leukaemic involvement of the central nervous system. 9 months after initial presentation she relapsed and reinduction with vincristine (2 mg/in2) and prednisolone was started. 4 days after the first dose of vincristine she was admitted to hospital with fever, vomiting, headache, and bone pain. Full blood examination showed Hb 11-4 mg/dl, total white cell count 400/mm3, and platelets 10 OOO/mm3. She was treated with intravenous antibiotics though all cultures were subsequently sterile. Melaena occurred that same evening and the following day a grand mal convulsion. Electrolytes taken at that time showed serum sodium 122 mEq/l, potassium 3-4 mEq/l, and urea 15 mg/100ml. Plasma and urine osmolalities were not performed as the significance of this syndrome was not appreciated.
She was treated with 0 5 mol/l saline and dextrose replacement but this resulted in considerable fluid overload. The abdomen remained distended and she passed frequent loose motions. A second injection of vincristine was given one week after the first but she remained leucopenic, gradually deteriorated, and died 14 days after the first injection of vincristine.
Necropsy findings. The brain was macroscopically normal with no signs of leukaemia or haemorrhage.
Microscopically the brain showed mild gliosis in the medulla and pons with neurons in the frontal cortex, thalamus, and hypothalamus showing chromatolysis, shrinkage, and pyknosis. 
Discussion
The clinical features in these 4 patients represent a recognizable pattern of bone marrow toxicity followed by abdominal distension, hyponatraemia, and convulsions. This combination of neural and bone marrow toxicity is characteristic of vincristine (Slater et al., 1969) . In one patient actinomycin D was associated with a similar spectrum of side effects but vincristine was administered concurrently. This spectrum of side effects was not associated with any of the other chemotherapeutic agents administered to our patients. Infection was presumed to be present in all cases, though only in Case 1 was there any evidence to substantiate its presence. Inexplicable neurological complications of tumours, though well documented in adults (Posner, 1971 ) seldom occur in children. There was no clinical evidence of tumour invasion of the central nervous system in any patient and likewise the necropsy findings in 2 patients did not show tumour in the central nervous system.
The detection of haematological toxicity depends largely on the timing of a blood examination. Neutropenia and thrombocytopenia were present by day 4 in 3 patients, and 48 hours after vincristine plus actinomycin D in Case 1. Blood examinations were not performed daily and it is possible that haematological manifestations of toxicity may have been evident before 4 days in all the patients. Abdominal distension with symptoms and signs of paralytic ileus occurred between days 4 and 7. Vincristine therapy is frequently complicated by abdominal pain, though paralytic ileus only occasionally occurs (Sandler, Tobin, and Henderson, 1969) . The ileus present in 3 of our 4 patients seems to represent one aspect of a generalized neurotoxic reaction to vincristine.
Hyponatraemia was present in 3 patients. The high urine osmolity in Case 1, the absence of clinical evidence for a reduced extracellular fluid volume, and the clinical response of Cases 2 and 3 to a saline load suggest an inappropriate secretion of ADH and this has been shown to occur with repeated vincristine injections in some patients (Stuart et al., 1975) . Convulsions occurred between days 6 and 8 in all patients. This and coma have been the cardinal signs of nondose-related vincristine neurotoxicity in other reports. Hyponatraemia was present at the time of the convulsion in Cases 2 and 3. In 4 patients described by Johnson et al., (1973) An explanation for this widespread idiosyncratic neurotoxic reaction to vincristine encompassing paralytic ileus, inappropriate ADH secretion, and convulsions is suggested by Shelanski and Wisniewski (1969) , who showed interference by the drug with the neurotubular system of the axon with proliferation of neurofilaments. This disruption of axonal flow caused an initial physiological disturbance of the axon followed by axonal degeneration, and finally an axonal reaction occurred in the nucleus. The time taken for this axonal reaction to occur varied, but with severe injury initial light microscope changes were present by 48 hours, and maximal changes were present by 12 days. 2 of our patients died 6 and 14 days after injection of vincristine and actinomycin D and of vincristine alone. Death was directly due to bronchopneumonia in Case 1 and haemorrhage and infection due to gangrenous bowel in Case 2. The necropsy changes in the brain of Case 1 showed no evidence of proliferation of neurofilaments or axonal degeneration as described by Shelanski and Wisniewski (1969) . This suggests that at least in this patient the toxic effects of therapeutic doses of vincristine on the brain were subtle and not associated with histological evidence of neuronal damage at the time that the clinical symptoms were apparent. Neuronal changes were present in Case 2, but there was no light microscope evidence of neurofibril proliferation, and the pattern of the changes was similar to that caused by anoxia. The lack of histological damage to the brain is consistent with the clinical experience that this syndrome is usually reversible and does not recur with subsequent administration of vincristine.
Although severe nondose-related vincristine toxicity is rare, it is necessary to be aware of the constellation of symptoms, signs, and laboratory findings. It is wise to anticipate inappropriate ADH secretion and convulsions when haematological side effects and marked abdominal distension develop after administration of a usually nontoxic dose of vincristine. 
